Under-fire NHS trust recorded patient ate breakfast three days after he died

Outside parliament, protesters made their voices heard as lawmakers debated a bill to legalize assisted dying. Supporters argue it’s about dignity and choice for the terminally ill, while opponents warn of ethical risks. The heated debate reflects deep societal divides on the issue.

Editor’s Note: This isn’t just another political vote—it’s a moral crossroads. The outcome could reshape how society treats end-of-life care, balancing personal autonomy against fears of misuse. Whatever side you’re on, it’s a debate that hits close to home for many.

A new PBS documentary dives into the often invisible struggles of family caregivers in the U.S., blending personal stories with a deep look at how policy failures have left millions to fend for themselves. It’s a raw, eye-opening exploration of why caregiving feels like an uphill battle—and who gets left behind when systems don’t support those doing the work.

Editor’s Note: Caregiving is a crisis hiding in plain sight—most of us will either need care or provide it at some point, yet the documentary exposes how little safety nets exist. This isn’t just about individual families; it’s a spotlight on how America’s patchwork approach to care punishes people for getting sick, growing old, or loving someone who does.

Ireland is shipping an unexpected—and incredibly valuable—cargo to the U.S. this year: $36 billion worth of hormones used in blockbuster weight-loss and diabetes drugs like Ozempic and Wegovy. These shipments are so massive that they’ve pushed Ireland, a small country of just five million, into becoming America’s second-largest trade deficit partner, right behind China.

Editor’s Note: This isn’t just a quirky trade stat—it’s a sign of how explosively in-demand these drugs have become. The fact that hormones are now more valuable than gold in U.S.-Ireland trade shows how much the pharmaceutical industry (and Ireland’s role in it) is booming. For patients, it’s a reminder of the huge market behind these life-changing medications—and maybe a hint that supply could finally be catching up to demand.

Ever heard of "tapping"? It’s a technique where you lightly tap on specific pressure points—like those used in acupuncture—to supposedly relieve stress, anxiety, or even physical pain. Some swear by it, though skeptics say the science isn’t quite there yet. Think of it as a DIY version of acupressure you can try at home.

Editor’s Note: Whether you're curious about stress hacks or just love exploring wellness trends, tapping is gaining buzz as a quick, no-cost tool. It’s not a magic fix, but for people looking for non-drug options, it’s worth knowing about—even if just to understand what friends (or influencers) are raving about.

British Columbia’s attorney general sees the recent U.S. settlement with Purdue Pharma and the Sackler family as a sign of growing legal pressure on opioid crisis players—just as a B.C.-led lawsuit against consulting firm McKinsey moves forward in Canada. The timing suggests momentum for holding corporations accountable for their alleged roles in fueling addiction.

Editor’s Note: This isn’t just another legal footnote—it’s part of a bigger push to make companies answer for the opioid epidemic. With Purdue’s settlement fresh and McKinsey now in the crosshairs, governments are signaling they won’t let corporate actors off the hook easily. For families affected by addiction, these cases could mean real accountability—or at least a step toward it.